262 related articles for article (PubMed ID: 6722846)
21. [Evaluation of flecainide in the therapy of chronic ventricular arrhythmia using the acute oral load method].
Schwartz PJ; Facchini M; Bonazzi O; Cuspidi C; Priori S; Varisco T; Zuanetti G
G Ital Cardiol; 1985 Mar; 15(3):273-82. PubMed ID: 4018465
[TBL] [Abstract][Full Text] [Related]
22. Flecainide: a new prototype antiarrhythmic agent.
Nappi JM; Anderson JL
Pharmacotherapy; 1985; 5(4):209-21. PubMed ID: 3898035
[TBL] [Abstract][Full Text] [Related]
23. Flecainide dose-response relations in stable ventricular arrhythmias.
Woosley RL; Siddoway LA; Duff HJ; Roden DM
Am J Cardiol; 1984 Feb; 53(5):59B-65B. PubMed ID: 6695819
[TBL] [Abstract][Full Text] [Related]
24. Effect of intravenous and oral flecainide on ventricular tachycardia.
Ward DE; Cheesman M; Dancy M
Int J Cardiol; 1986 Mar; 10(3):251-62. PubMed ID: 3957470
[TBL] [Abstract][Full Text] [Related]
25. Suppression of resistant ventricular arrhythmias by twice daily dosing with flecainide.
Duff HJ; Roden DM; Maffucci RJ; Vesper BS; Conard GJ; Higgins SB; Oates JA; Smith RF; Woosley RL
Am J Cardiol; 1981 Dec; 48(6):1133-40. PubMed ID: 7304461
[No Abstract] [Full Text] [Related]
26. Flecainide in the treatment of nonsustained ventricular tachycardia.
Lal R; Chapman PD; Naccarelli GV; Schechtman KB; Rinkenberger RL; Troup PJ; Kim SS; Dougherty AH; Ruffy R
Ann Intern Med; 1986 Oct; 105(4):493-8. PubMed ID: 3752754
[TBL] [Abstract][Full Text] [Related]
27. [Study of flecainide in the treatment of ventricular arrhythmia].
Hug C; Koliopoulos N; Tardy C; Errera J; Puech P
Ann Cardiol Angeiol (Paris); 1983 May; 32(3):161-4. PubMed ID: 6193751
[TBL] [Abstract][Full Text] [Related]
28. Flecainide: long-term treatment using a reduced dosing schedule.
Flowers D; O'Gallagher D; Torres V; Miura D; Somberg JC
Am J Cardiol; 1985 Jan; 55(1):79-83. PubMed ID: 3966401
[TBL] [Abstract][Full Text] [Related]
29. Suppression of ventricular ectopic depolarizations by flecainide acetate, a new antiarrhythmic agent.
Hodges M; Haugland JM; Granrud G; Conard GJ; Asinger RW; Mikell FL; Krejci J
Circulation; 1982 May; 65(5):879-85. PubMed ID: 7074749
[TBL] [Abstract][Full Text] [Related]
30. Antiarrhythmic effects of flecainide.
Somani P
Clin Pharmacol Ther; 1980 Apr; 27(4):464-70. PubMed ID: 7357804
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of flecainide in the management of ventricular arrhythmias: comparative study with amiodarone.
Dubner SJ; Elencwajg BD; Palma S; Mendelzon R; Ramos A; Bertolasi CA
Am Heart J; 1985 Mar; 109(3 Pt 1):523-8. PubMed ID: 3883728
[TBL] [Abstract][Full Text] [Related]
32. Clinical and electrophysiologic assessment of oral flecainide acetate for recurrent ventricular tachycardia: evidence for exacerbation of electrical instability.
Oetgen WJ; Tibbits PA; Abt ME; Goldstein RE
Am J Cardiol; 1983 Oct; 52(7):746-50. PubMed ID: 6624666
[TBL] [Abstract][Full Text] [Related]
33. Total suppression of ventricular arrhythmias by encainide. Pharmacokinetic and electrocardiographic characteristics.
Roden DM; Reele SB; Higgins SB; Mayol RF; Gammans RE; Oates JA; Woosley RL
N Engl J Med; 1980 Apr; 302(16):877-82. PubMed ID: 6767186
[TBL] [Abstract][Full Text] [Related]
34. Flecainide: steady state electrophysiologic effects in patients with remote myocardial infarction and inducible sustained ventricular arrhythmia.
Webb CR; Morganroth J; Senior S; Spielman SR; Greenspan AM; Horowitz LN
J Am Coll Cardiol; 1986 Jul; 8(1):214-20. PubMed ID: 3711519
[TBL] [Abstract][Full Text] [Related]
35. The proarrhythmic effects of flecainide.
Nathan AW; Hellestrand KJ; Bexton RS; Spurrell RA; Camm AJ
Drugs; 1985; 29 Suppl 4():45-53. PubMed ID: 4006779
[TBL] [Abstract][Full Text] [Related]
36. [Effects of oral and injectable flecainide in patients with an accessory atrioventricular pathway].
Fauchier JP; Cosnay P; Rouesnel P; Moquet B; Bonnet P; Scala PJ; Demeyer JF
Arch Mal Coeur Vaiss; 1985 Oct; 78 Spec No():81-90. PubMed ID: 3938264
[TBL] [Abstract][Full Text] [Related]
37. Conversion of supraventricular arrhythmias to sinus rhythm using flecainide.
Goy JJ; Grbic M; Hurni M; Finci L; Maendly R; Duc J; Sigwart U
Eur Heart J; 1985 Jun; 6(6):518-24. PubMed ID: 4043101
[TBL] [Abstract][Full Text] [Related]
38. Treatment of resistant ventricular tachycardia with flecainide acetate. Flecainide Ventricular Tachycardia Study Group.
Am J Cardiol; 1986 Jun; 57(15):1299-304. PubMed ID: 3717029
[TBL] [Abstract][Full Text] [Related]
39. Antiarrhythmic therapy with flecainide in combination and comparison with propranolol.
Stern H; Scheininger M; Theisen F; Theisen K
Drugs; 1985; 29 Suppl 4():77-85. PubMed ID: 4006784
[TBL] [Abstract][Full Text] [Related]
40. Electrocardiographic and electrophysiologic effects of pirmenol in ventricular tachycardia.
Estes NA; Gold R; Cameron J; Haffajee C; Marshall M; Mack K; Salem DN
Am J Cardiol; 1987 Jun; 59(16):20H-26H. PubMed ID: 3591711
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
